TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 1,086,900 shares, adeclineof38.8% from the July 15th total of 1,775,700 shares. Currently,0.5% of the shares of the company are short sold. Based on an average trading volume of 870,900 shares, the days-to-cover ratio is currently 1.2 days. Based on an average trading volume of 870,900 shares, the days-to-cover ratio is currently 1.2 days. Currently,0.5% of the shares of the company are short sold.
TerrAscend Price Performance
TerrAscend stock opened at $0.97 on Tuesday. TerrAscend has a 52 week low of $0.23 and a 52 week high of $1.75. The company has a quick ratio of 1.07, a current ratio of 1.45 and a debt-to-equity ratio of 1.94. The firm's 50-day simple moving average is $0.40 and its 200 day simple moving average is $0.42. The firm has a market capitalization of $297.70 million, a PE ratio of -2.37 and a beta of 1.39.
TerrAscend (OTCMKTS:TSNDF - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.01). TerrAscend had a negative return on equity of 23.19% and a negative net margin of 40.86%. The business had revenue of $65.01 million during the quarter, compared to analysts' expectations of $64.87 million. On average, equities research analysts predict that TerrAscend will post -0.14 EPS for the current fiscal year.
Analyst Ratings Changes
Separately, Atb Cap Markets raised shares of TerrAscend from a "hold" rating to a "strong-buy" rating in a research note on Thursday, May 8th.
View Our Latest Report on TSNDF
About TerrAscend
(
Get Free Report)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TerrAscend, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.
While TerrAscend currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.